TREATMENT OF GASTROINTESTINAL BLEEDING IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWF

• 收藏
• 分享

专利权人:

Baxalta Incorporated;Baxalta GmbH

发明人:

Miranda Chapman,Bruce Ewenstein,Bettina Ploder

申请号：

US16802118

公开号：

US20200206318A1

申请日:

2020.02.26

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention relates to a method for treating gastrointestinal bleeding in a subject with severe von Willebrand Disease comprising administering to the subject at least one dose of recombinant von Willebrand Factor (rVWF) ranging from about 40 IU/kg to about 100 IU/kg, wherein the first dose further comprises recombinant Factor VIII (rFVIII).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/